Publications by authors named "Rong-Yan Lin"
Hexanuclear polyoxomolybdenum-based discrete supermolecules Na[MoO(μ-O)(Htrz)(trz)]·HO ( = 0, = 15, 1; = 1, = 12, 2; = 2, = 10, 3; = 2, = 49, 4; Htrz = 1-1,2,3-triazole) have been prepared and fully characterized with different amounts of sodium cations inside and outside the intrinsic holes. Structural analyses demonstrate that they all exist a triangular channel constructed by six molybdenum-oxygen groups with inner diameters of 2.86 (1), 2.
View Article and Find Full Text PDFBy adjusting the pH values of the solutions, binuclear, tetranuclear and hexadecanuclear glycolato thio- and oxomolybdenum(V/IV) complexes [MoV2O(μ-O)(μ-S)(Hglyc)(Hpz)]·HO (1, Hglyc = glycolic acid, Hpz = pyrazole), (Hdpa)[MoV2O(μ-S)(Hglyc)(glyc)(HO)] (2, dpa = 2,2'-dipyridylamine), (Hdpa)[MoV4O(μ-O)(μ-S)(glyc)(SO)] (3) and Na[MoIV4MoV12O(μ-O)(μ-OH)(μ-O)(glyc)(Hpz)(pz)]·28HO (4) have been obtained successfully. Here the glycolates existed in varying aggregates with different degrees of protonation and deprotonation in 1-4. The stable formations of 1 and 2 are attributed to strong hydrogen bonds formed between the molecules.
View Article and Find Full Text PDFArticle Synopsis
- Researchers have synthesized and characterized various porous materials consisting of multiple metal-oxo clusters known as polyoxometalates (POMs), specifically dodecanuclear, icosanuclear, and octanuclear types.
- These materials exhibit diverse pore structures formed by their unique molecular formations and interactions with water molecules, which are essential for their potential applications.
- Notably, one of the materials, referred to as 1, shows superior capability for CO gas adsorption compared to other gases, highlighting its potential use in gas storage and separation technologies.
Objective: To analyze the efficacy and survival associated factors of gefitinib combined with cisplatin and gemcitabine for advanced non-small cell lung cancer.
Materials And Methods: A total of 57 patients with advanced non-small cell lung cancer (NSCLC), who received platinum-based chemotherapy regimens for more than 1 cycle, were treated with gefitinib combined with cisplatin and gemcitabine until disease progression. Efficacy, survival time and adverse reactions were observed.